145 related articles for article (PubMed ID: 37263539)
1. Microbiota and Nod-like receptors balance inflammation and metabolism during obesity and diabetes.
Rodrigues E-Lacerda R; Fang H; Robin N; Bhatwa A; Marko DM; Schertzer JD
Biomed J; 2023 Oct; 46(5):100610. PubMed ID: 37263539
[TBL] [Abstract][Full Text] [Related]
2. Postbiotics for NOD2 require nonhematopoietic RIPK2 to improve blood glucose and metabolic inflammation in mice.
Cavallari JF; Barra NG; Foley KP; Lee A; Duggan BM; Henriksbo BD; Anhê FF; Ashkar AA; Schertzer JD
Am J Physiol Endocrinol Metab; 2020 Apr; 318(4):E579-E585. PubMed ID: 32101030
[TBL] [Abstract][Full Text] [Related]
3. Muramyl Dipeptide-Based Postbiotics Mitigate Obesity-Induced Insulin Resistance via IRF4.
Cavallari JF; Fullerton MD; Duggan BM; Foley KP; Denou E; Smith BK; Desjardins EM; Henriksbo BD; Kim KJ; Tuinema BR; Stearns JC; Prescott D; Rosenstiel P; Coombes BK; Steinberg GR; Schertzer JD
Cell Metab; 2017 May; 25(5):1063-1074.e3. PubMed ID: 28434881
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota-based vaccination engages innate immunity to improve blood glucose control in obese mice.
Duggan BM; Tamrakar AK; Barra NG; Anhê FF; Paniccia G; Wallace JG; Stacey HD; Surette MG; Miller MS; Sloboda DM; Schertzer JD
Mol Metab; 2022 Jan; 55():101404. PubMed ID: 34839023
[TBL] [Abstract][Full Text] [Related]
5. Postbiotics engage IRF4 in adipocytes to promote sex-dependent changes in blood glucose during obesity.
Duggan BM; Singh AM; Chan DY; Schertzer JD
Physiol Rep; 2022 Aug; 10(16):e15439. PubMed ID: 35993451
[TBL] [Abstract][Full Text] [Related]
6. Understanding and modulating the Toll like Receptors (TLRs) and NOD like Receptors (NLRs) cross talk in type 2 diabetes.
Prajapati B; Jena PK; Rajput P; Purandhar K; Seshadri S
Curr Diabetes Rev; 2014 May; 10(3):190-200. PubMed ID: 24828062
[TBL] [Abstract][Full Text] [Related]
7. Metabolic endotoxemia is dictated by the type of lipopolysaccharide.
Anhê FF; Barra NG; Cavallari JF; Henriksbo BD; Schertzer JD
Cell Rep; 2021 Sep; 36(11):109691. PubMed ID: 34525353
[TBL] [Abstract][Full Text] [Related]
8. NOD2 Deficiency Promotes Intestinal CD4+ T Lymphocyte Imbalance, Metainflammation, and Aggravates Type 2 Diabetes in Murine Model.
Carlos D; Pérez MM; Leite JA; Rocha FA; Martins LMS; Pereira CA; Fraga-Silva TFC; Pucci TA; Ramos SG; Câmara NOS; Bonato VLD; Tostes RC; Silva JS
Front Immunol; 2020; 11():1265. PubMed ID: 32774333
[TBL] [Abstract][Full Text] [Related]
9. Role of microbiota-derived lipopolysaccharide in adipose tissue inflammation, adipocyte size and pyroptosis during obesity.
Hersoug LG; Møller P; Loft S
Nutr Res Rev; 2018 Dec; 31(2):153-163. PubMed ID: 29362018
[TBL] [Abstract][Full Text] [Related]
10. RIPK2 Dictates Insulin Responses to Tyrosine Kinase Inhibitors in Obese Male Mice.
Duggan BM; Cavallari JF; Foley KP; Barra NG; Schertzer JD
Endocrinology; 2020 Aug; 161(8):. PubMed ID: 32473019
[TBL] [Abstract][Full Text] [Related]
11. A casein hydrolysate protects mice against high fat diet induced hyperglycemia by attenuating NLRP3 inflammasome-mediated inflammation and improving insulin signaling.
Healy NP; Kirwan AM; McArdle MA; Holohan K; Nongonierma AB; Keane D; Kelly S; Celkova L; Lyons CL; McGillicuddy FC; Finucane OM; Murray BA; Kelly PM; Brennan L; FitzGerald RJ; Roche HM
Mol Nutr Food Res; 2016 Nov; 60(11):2421-2432. PubMed ID: 27390025
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine kinase inhibitors of Ripk2 attenuate bacterial cell wall-mediated lipolysis, inflammation and dysglycemia.
Duggan BM; Foley KP; Henriksbo BD; Cavallari JF; Tamrakar AK; Schertzer JD
Sci Rep; 2017 May; 7(1):1578. PubMed ID: 28484277
[TBL] [Abstract][Full Text] [Related]
13. NOD1 activators link innate immunity to insulin resistance.
Schertzer JD; Tamrakar AK; Magalhães JG; Pereira S; Bilan PJ; Fullerton MD; Liu Z; Steinberg GR; Giacca A; Philpott DJ; Klip A
Diabetes; 2011 Sep; 60(9):2206-15. PubMed ID: 21715553
[TBL] [Abstract][Full Text] [Related]
14. Cholinergic drugs reduce metabolic inflammation and diabetic myocardial injury by regulating the gut bacterial component lipopolysaccharide-induced ERK/Egr-1 pathway.
Wu Q; Zhao M; Li D; He X; Zang W
FASEB J; 2023 May; 37(5):e22917. PubMed ID: 37039813
[TBL] [Abstract][Full Text] [Related]
15. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance.
Vandanmagsar B; Youm YH; Ravussin A; Galgani JE; Stadler K; Mynatt RL; Ravussin E; Stephens JM; Dixit VD
Nat Med; 2011 Feb; 17(2):179-88. PubMed ID: 21217695
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of NOD1 or NOD2 and TLR4 activation on mouse sickness behavior in relation to immune and brain activity markers.
Farzi A; Reichmann F; Meinitzer A; Mayerhofer R; Jain P; Hassan AM; Fröhlich EE; Wagner K; Painsipp E; Rinner B; Holzer P
Brain Behav Immun; 2015 Feb; 44():106-20. PubMed ID: 25218901
[TBL] [Abstract][Full Text] [Related]
17. Convergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain (NOD) expression and signaling in monocytes from patients with type 2 diabetes.
Shiny A; Regin B; Balachandar V; Gokulakrishnan K; Mohan V; Babu S; Balasubramanyam M
Cytokine; 2013 Nov; 64(2):564-70. PubMed ID: 24018334
[TBL] [Abstract][Full Text] [Related]
18. Peripheral and central regulation of insulin by the intestine and microbiome.
Schertzer JD; Lam TKT
Am J Physiol Endocrinol Metab; 2021 Feb; 320(2):E234-E239. PubMed ID: 33308015
[TBL] [Abstract][Full Text] [Related]
19. NOD-like Receptors-Emerging Links to Obesity and Associated Morbidities.
Bauer S; Hezinger L; Rexhepi F; Ramanathan S; Kufer TA
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239938
[TBL] [Abstract][Full Text] [Related]
20. Innate sensors of pathogen and stress: linking inflammation to obesity.
Jin C; Flavell RA
J Allergy Clin Immunol; 2013 Aug; 132(2):287-94. PubMed ID: 23905917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
